Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: Current antimicrobial resistances and susceptibilities

Experimental Dermatology

Volumn 17, Issue 11, 2008, Pages 953-957

  Niebuhr, Margarete ^a   Mai, Uwe ^b   Kapp, Alexander ^a   Werfel, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Klinikum Region Hannover   (Germany)

Author keywords

Antimicrobial susceptibility; Atopic dermatitis; Staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT DEPARTMENT; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; YOUNG ADULT;

EID: 54049144288     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00734.x     Document Type: Article

References (25)

1. Kapp A. Atopic dermatitis - the skin manifestation of atopy. Clin Exp Allergy 1995: 25: 210-219.
2. Werfel T, Kapp A. Environmental and other major provocation factors in atopic dermatitis. Allergy 1998: 53: 731-739.
3. Leyden JE, Marples RR, Kligmann AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974: 90: 525-530.
4. Matsui K, Nishikawa A, Suto H et al. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis. Microbiol Immunol 2000: 44: 945-947.
5. Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy 2001: 56: 1034-1041.
6. Breuer K, Wittmann M, Bosche B et al. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000: 55: 551-555.
7. Leung DYM, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest 1993: 92: 1374-1380.
8. Skov L, Olsen JV, Giorno L. et al. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T-cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000: 105: 820-826.
9. Mc Fadden JP, Noble WC, Camp RDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993: 128: 631-632.
10. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Eng J Med 2002: 347: 1151-1160.
11. Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol 2007: 33: 167-177.
12. Breuer K, Häussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002: 147: 55-61.
13. Vollmert C, Behrendt H. Bactericidal activity of flucloxacillin against S. sureus in primary keratinocyte cultures of lesional and unaffected skin of patients suffering from atopic dermatitis. Exp Dermatol 2005: 14: 215-224.
14. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980: 92 (Suppl.): 44-47.
15. Hoeger PH. Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatr Allergy Immunol 2004: 15: 474-477.
16. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet 1996: 347: 1271-1272.
17. Kresken M, Hafner D, Schmitz F-J, Wichelhaus T.A. für die Studiengruppe. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfung und Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.aus dem Jahre 2004. Antiinfectives Intelligence, Rheinbach 2006.
18. Moet GJ, Jones RN, Biedenbach DJ et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007: 57: 7-13.
19. Lietzau S, Sturmer T, Erb A et al. Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany. Epidemiol Infect 2004: 132: 655-662.
20. Schöfer H, Brockmeyer N, Dissemond J et al. Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology. J Dtsch Dermatol Ges 2005: 3: 726-34.
21. Sugeng MW, Ang P, Tan HH, Goh CL. Characteristics of bacterial skin infections in children compared to adults at a tertiary dermatologic center. Int J Dermatol 1999: 38: 582-586.
22. Jones ME, Schmitz FJ, Fluit AC et al. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance programme. Eur J Microbiol Infect Dis 1999: 18: 403-408.
23. Darmstadt GL. Antibiotics in the management of pediatric skin disease. Dermatol Clin 1998: 16: 509-525.
24. Ravencroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 2000: 25: 327-330.
25. Shah M, Mohanraj M. High levels of fusidic acid resistant Staphylococcus aureus in dermatology patients. Br J Dermatol 2003: 148: 1018-1020.